vs
Side-by-side financial comparison of Globalstar, Inc. (GSAT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $72.0M, roughly 1.0× Globalstar, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 17.6%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 12.9%).
Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
GSAT vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.0M | $75.5M |
| Net Profit | $-11.6M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -0.5% | 22.7% |
| Net Margin | -16.1% | — |
| Revenue YoY | 17.6% | 27.7% |
| Net Profit YoY | 76.9% | — |
| EPS (diluted) | $-0.11 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $72.0M | $75.5M | ||
| Q3 25 | $73.8M | $54.5M | ||
| Q2 25 | $67.1M | $52.4M | ||
| Q1 25 | $60.0M | $46.0M | ||
| Q4 24 | $61.2M | $59.1M | ||
| Q3 24 | $72.3M | $80.5M | ||
| Q2 24 | $60.4M | $47.1M | ||
| Q1 24 | $56.5M | $43.8M |
| Q4 25 | $-11.6M | — | ||
| Q3 25 | $1.1M | $8.8M | ||
| Q2 25 | $19.2M | $5.9M | ||
| Q1 25 | $-17.3M | $3.0M | ||
| Q4 24 | $-50.2M | — | ||
| Q3 24 | $9.9M | $20.3M | ||
| Q2 24 | $-9.7M | $-4.5M | ||
| Q1 24 | $-13.2M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | -0.5% | 22.7% | ||
| Q3 25 | 13.8% | 17.6% | ||
| Q2 25 | 9.2% | 12.7% | ||
| Q1 25 | -14.2% | 8.7% | ||
| Q4 24 | -6.9% | 22.6% | ||
| Q3 24 | 13.0% | 27.4% | ||
| Q2 24 | -2.4% | -4.6% | ||
| Q1 24 | -8.3% | -5.3% |
| Q4 25 | -16.1% | — | ||
| Q3 25 | 1.5% | 16.2% | ||
| Q2 25 | 28.6% | 11.2% | ||
| Q1 25 | -28.9% | 6.5% | ||
| Q4 24 | -82.1% | — | ||
| Q3 24 | 13.7% | 25.2% | ||
| Q2 24 | -16.0% | -9.6% | ||
| Q1 24 | -23.4% | -11.0% |
| Q4 25 | $-0.11 | $0.26 | ||
| Q3 25 | $-0.01 | $0.17 | ||
| Q2 25 | $0.13 | $0.12 | ||
| Q1 25 | $-0.16 | $0.06 | ||
| Q4 24 | $-0.57 | $0.40 | ||
| Q3 24 | $0.00 | $0.41 | ||
| Q2 24 | $-0.01 | $-0.09 | ||
| Q1 24 | $-0.01 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $447.5M | $97.5M |
| Total DebtLower is stronger | $483.8M | $22.7M |
| Stockholders' EquityBook value | $355.7M | $130.3M |
| Total Assets | $2.3B | $216.3M |
| Debt / EquityLower = less leverage | 1.36× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $447.5M | $97.5M | ||
| Q3 25 | $346.3M | $94.4M | ||
| Q2 25 | $308.2M | $96.0M | ||
| Q1 25 | $241.4M | $93.2M | ||
| Q4 24 | $391.2M | $101.0M | ||
| Q3 24 | $51.9M | $96.7M | ||
| Q2 24 | $64.3M | $96.8M | ||
| Q1 24 | $59.3M | $107.2M |
| Q4 25 | $483.8M | $22.7M | ||
| Q3 25 | $508.6M | $34.0M | ||
| Q2 25 | $491.5M | $45.3M | ||
| Q1 25 | $502.7M | $56.7M | ||
| Q4 24 | $511.4M | $68.0M | ||
| Q3 24 | $394.4M | $79.3M | ||
| Q2 24 | $393.1M | $90.7M | ||
| Q1 24 | $398.7M | $102.0M |
| Q4 25 | $355.7M | $130.3M | ||
| Q3 25 | $364.8M | $115.3M | ||
| Q2 25 | $360.9M | $104.7M | ||
| Q1 25 | $344.3M | $97.1M | ||
| Q4 24 | $358.9M | $92.1M | ||
| Q3 24 | $394.1M | $71.1M | ||
| Q2 24 | $383.0M | $48.5M | ||
| Q1 24 | $377.1M | $51.0M |
| Q4 25 | $2.3B | $216.3M | ||
| Q3 25 | $2.2B | $202.9M | ||
| Q2 25 | $1.9B | $194.9M | ||
| Q1 25 | $1.7B | $196.2M | ||
| Q4 24 | $1.7B | $213.3M | ||
| Q3 24 | $917.6M | $220.7M | ||
| Q2 24 | $926.2M | $205.0M | ||
| Q1 24 | $917.0M | $214.1M |
| Q4 25 | 1.36× | 0.17× | ||
| Q3 25 | 1.39× | 0.30× | ||
| Q2 25 | 1.36× | 0.43× | ||
| Q1 25 | 1.46× | 0.58× | ||
| Q4 24 | 1.43× | 0.74× | ||
| Q3 24 | 1.00× | 1.12× | ||
| Q2 24 | 1.03× | 1.87× | ||
| Q1 24 | 1.06× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.9M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.9M | $14.4M | ||
| Q3 25 | $236.0M | $9.7M | ||
| Q2 25 | $157.9M | $14.1M | ||
| Q1 25 | $51.9M | $3.6M | ||
| Q4 24 | $340.7M | $15.6M | ||
| Q3 24 | $32.0M | $11.0M | ||
| Q2 24 | $36.7M | $1.0M | ||
| Q1 24 | $29.8M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 216.53× | 1.10× | ||
| Q2 25 | 8.22× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.23× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSAT
| Services | $67.4M | 94% |
| Products | $4.6M | 6% |
PBYI
Segment breakdown not available.
